ADCC-Enhanced anti-ACVR2B biobetter

0 votes
asked Mar 18, 2021 in Cell Tracking by creativebiolabs22 (11,380 points)

ADCC-Enhanced anti-Activin Beta-B (46A/F) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells.

ADCC-Enhanced anti-ACVR2B biobetter

Please log in or register to answer this question.

Welcome to Bioimagingcore Q&A, where you can ask questions and receive answers from other members of the community.
...